CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
14.90
+1.39 (10.29%)
At close: Dec 20, 2024, 4:00 PM
14.77
-0.13 (-0.87%)
After-hours: Dec 20, 2024, 4:23 PM EST

CARGO Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Net Income
-154.14-98.15-40.95-5.85
Depreciation & Amortization
6.813.691.440.15
Asset Writedown & Restructuring Costs
0.551.511.01-
Stock-Based Compensation
14.763.330.30.51
Other Operating Activities
0.446.256.16-
Change in Accounts Payable
-1.490.762.820.33
Change in Other Net Operating Assets
3.311.450.15-0.08
Operating Cash Flow
-133.84-81.16-29.07-4.94
Capital Expenditures
-6.43-8.28-2.72-0.44
Sale (Purchase) of Intangibles
-1.31-0.72-0.56-
Investing Cash Flow
-336.32-8.99-3.28-0.44
Short-Term Debt Issued
-3.528.45-
Total Debt Issued
-3.528.45-
Net Debt Issued (Repaid)
-3.528.45-
Issuance of Common Stock
400.41296.640.23-
Other Financing Activities
-4.84-5.47--
Financing Cash Flow
481.56494.5834.195.41
Net Cash Flow
11.4404.431.830.03
Free Cash Flow
-140.27-89.44-31.8-5.38
Free Cash Flow Per Share
-3.65-15.06-81.06-35.32
Levered Free Cash Flow
-112.93-68.1-7.91-
Unlevered Free Cash Flow
-112.93-67.1-4.82-
Change in Net Working Capital
19.144.68-18.45-
Source: S&P Capital IQ. Standard template. Financial Sources.